Q4 2025 Mentice AB Earnings Call Transcript
Key Points
- Mentice AB (FRA:MN2) reported an encouraging sale of SEK91 million for Q4, marking an organic growth of 18%.
- The company achieved an improved EBITDA margin of 25%, up from 19% the previous year, reflecting higher sales and effective cost measures.
- Order intake showed strong performance with SEK127 million, representing an organic growth of 25%.
- The strategic consolidation of the physical simulation business to Denver is expected to enhance cost structure and operational efficiency.
- Mentice AB (FRA:MN2) is experiencing strong growth in the medical device industry segment, particularly in the Americas and Asia Pacific regions.
- Full-year net sales were SEK279 million, a slight decrease from SEK290 million the previous year, impacted by foreign exchange rates.
- The EMEA region's performance was neutral, showing no significant growth compared to the previous year.
- Operational cash flow was lower than the same quarter in 2024 due to increased sales leading to higher working capital and accounts receivables.
- The healthcare systems segment has been declining, with strategic initiatives yet to yield significant results.
- Software sales were down year-over-year, attributed to timing issues related to hardware installations.
Good morning and welcome everyone. My name is Richard Engberg, and I'm an equity research analyst here at DMB Carnegie. With me, I have Frans Venker, CEO, and Ulrika Voksepp, CFO of Mentice, and today we're going to present the fourth quarter of Mentice. Frans and Ulrika, the stage is yours.
No, thank you, Richard. Thanks for having me. It is, we have, Ulrika from Gothenburg. Unfortunately, she could not be here, so we are basically Ulrika's virtually, and I'm here in person.
So, what we have today, for you is first of all the highlights, for the Q4 results, as also the financial results, by Ulrika, our Chief Financial Officer. I will provide, concluding remarks and then we can go towards the Q&A.
So overall what we saw for the quarter, and this is also the summary to it, we saw an encouraging sale of SEK91 million. And so that meant an organic growth of 18% and that was equivalent to 5% if you compare that or basically correct that for foreign exchange and the especially
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
